Group Members

I am currently a Research Associate at the Newcastle University Centre for Cancer, focusing on the development of population pharmacokinetic models for paediatric oncology.

Previous qualifications and experience

• 2021-2023 - Postdoctoral Researcher in DMPK of novel psychoactive substances, University of Dundee.
• 2017-2022 - PhD in Detection and metabolism of psychoactive substances in a polydrug context, University of Dundee.
• 2018-2019 - Postgraduate Certificate (PGCert) in Research Development, University of Dundee.
• 2015-2016 - MSc in Instrumental Analytical Science (Drug Analysis & Toxicology), Robert Gordon University.
• 2011-2015 - BSc (Hons) in Forensic and Analytical Science, Robert Gordon University.

• Articles

  • Brandon AM, Baginski SR, Peet C, Dugard P, Gréen H, Sutcliffe OB, Nic Daéid N, Nisbet LA, Read KD, McKenzie C. Log D_7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity. Drug Testing and Analysis 2024, 16(9), 1012-1025.
  • Marland V, Reid R, Brandon AM, Hill K, Cruickshanks F, McKenzie C, Norman C, Daéid NN, Menard H. Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence and modes of use. Drug Testing and Analysis 2024, 16(5), 457-472.
  • Brandon AM, Antonides LH, Riley J, Epemolu O, McKeown DA, Read KD, McKenzie C. A systematic study of the in vitro pharmacokinetics and estimated human in vivo clearance of indole and indazole-3-carboxamide synthetic cannabinoid receptor agonists detected on the illicit drug market. Molecules 2021, 26(5), 1396.

• Review

  • Berezowska M, Hayden IS, Brandon AM, Zats A, Patel M, Barnett S, Ogungbenro K, Veal GJ, Taylor A, Suthar J. Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice. British Journal of Clinical Pharmacology 2024, epub ahead of print.